Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting ROR1 in combination with osimertinib in EGFR mutant lung cancer cells.
Nakagawa N, Miyake N, Ochi N, Yamane H, Takeyama M, Nagasaki Y, Ikeda T, Yokota E, Fukazawa T, Nakanishi H, Harada D, Kiura K, Takigawa N. Nakagawa N, et al. Among authors: nagasaki y. Exp Cell Res. 2021 Dec 15;409(2):112940. doi: 10.1016/j.yexcr.2021.112940. Epub 2021 Nov 19. Exp Cell Res. 2021. PMID: 34808132
High Uptake of FDG Along a Biliary Stent.
Nagasaki Y, Yamane H, Ochi N, Honda Y, Takigawa N. Nagasaki Y, et al. Clin Nucl Med. 2016 Nov;41(11):890-891. doi: 10.1097/RLU.0000000000001357. Clin Nucl Med. 2016. PMID: 27607171 Free PMC article.
Ceftriaxone-associated pancreatitis captured on serial computed tomography scans.
Nakagawa N, Ochi N, Yamane H, Honda Y, Nagasaki Y, Urata N, Nakanishi H, Kawamoto H, Takigawa N. Nakagawa N, et al. Among authors: nagasaki y. Radiol Case Rep. 2017 Dec 2;13(1):43-46. doi: 10.1016/j.radcr.2017.10.022. eCollection 2018 Feb. Radiol Case Rep. 2017. PMID: 29487636 Free PMC article.
Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17.
Yamane H, Ochi N, Nagasaki Y, Yamagishi T, Honda Y, Nakagawa N, Takeyama M, Nakanishi H, Takigawa N. Yamane H, et al. Among authors: nagasaki y. Ther Clin Risk Manag. 2018 Aug 21;14:1457-1465. doi: 10.2147/TCRM.S169824. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 30174428 Free PMC article.
Descending necrotizing mediastinitis in a healthy young adult.
Ochi N, Wakabayashi T, Urakami A, Yamatsuji T, Ikemoto N, Nagasaki Y, Nakagawa N, Honda Y, Nakanishi H, Yamane H, Monobe Y, Akisada T, Katayama H, Naomoto Y, Takigawa N. Ochi N, et al. Among authors: nagasaki y. Ther Clin Risk Manag. 2018 Oct 17;14:2013-2017. doi: 10.2147/TCRM.S176520. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 30425498 Free PMC article.
Wandering consolidation.
Kawahara T, Ochi N, Kato K, Shibamoto K, Nagasaki Y, Nakagawa N, Nakanishi H, Yamane H, Monobe Y, Takigawa N. Kawahara T, et al. Among authors: nagasaki y. Thorax. 2019 Aug;74(8):821-822. doi: 10.1136/thoraxjnl-2018-212059. Epub 2019 May 29. Thorax. 2019. PMID: 31142618 Free PMC article. No abstract available.
Targeting ROR1 in combination with pemetrexed in malignant mesothelioma cells.
Miyake N, Ochi N, Yamane H, Fukazawa T, Ikeda T, Yokota E, Takeyama M, Nakagawa N, Nakanishi H, Kohara H, Nagasaki Y, Kawahara T, Ichiyama N, Yamatsuji T, Naomoto Y, Takigawa N. Miyake N, et al. Among authors: nagasaki y. Lung Cancer. 2020 Jan;139:170-178. doi: 10.1016/j.lungcan.2019.10.024. Epub 2019 Nov 2. Lung Cancer. 2020. PMID: 31809978
360 results